InvestorsHub Logo
icon url

flipper44

03/30/16 1:25 PM

#57903 RE: Ready4bluesky #57900

Actually, I'm excited for dendritic therapy prospects against lung cancer. You need not provide sympathy for me. ARGS and Nwbo could end up covering the spectrum. Direct for stage 4, which makes up 40% of nsclc, and ags-003 for stages 1,2 and 3. ARGS was stalled for a while as well, but they finally started their lung cancer safety trial. I wish them the best.